Search results
Results From The WOW.Com Content Network
Communicate accurate legal information to attorneys and pharmacists. Foster knowledge and education pertaining to the rights and duties of pharmacists. Distribute information of interest to the membership via a newsletter and other appropriate publications. Provide a forum for the exchange of information pertaining to pharmacy law.
Legal claims against the pharmaceutical industry have varied widely over the past two decades, including Medicare and Medicaid fraud, off-label promotion, and inadequate manufacturing practices. [ 3 ] [ 4 ] With respect to off-label promotion, specifically, a federal court recognized off-label promotion as a violation of the False Claims Act ...
The first online pharmacy in the U.K. was Pharmacy2U, which started operating in 1999. [67] The UK is a frontline leader in internet pharmacies since a change to NHS pharmacy regulations in 2005 that made it legal for pharmacies to fill NHS prescriptions over the Internet. [68]
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
The nursing home pharmacy manager, Omnicare, was a big part of that plan. By the summer of 2000, Johnson & Johnson would sign a new, more extensive deal with the company. One of the J&J executives on the account crowed in a memo about “Omnicare’s ability to persuade physicians to write Risperdal in the areas of Behavioral Disturbances ...
DiRx, an online pharmacy dealing in generics that is licensed in all 50 states and Washington, D.C., is doing the same thing Walgreens intends to do. "This came up even earlier when the Roe v ...
The company was in a legal dispute in late 2018 over the rights of the contact details of members of the National Pharmacy Association. The presiding judge expressed concerns over the company's ability to "pick off" individual members. [16] As of May 2019, Pharmacy2U has over 350,000 nominated EPS patients.
In 1999, Johnson & Johnson had signed a contract with a company called Excerpta Medica. Its specialty was medical marketing. Its sub-specialty was producing ghostwritten, data-filled studies on the efficacy and safety of a client’s drugs, finding the right academic scholars to be listed as the authors and then placing the articles in prestigious academic journals.